ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,713Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 823

$1.61M Total Retail Price of All Prescriptions

Rank: 13 out of 823

513 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 513 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 8,222 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$165 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
CRESTOR 818 689 1 20
RAMIPRIL 707 636 10 2 69
LEVOTHYROXINE SODIUM 619 518 3 6
ACTOS 598 531 10 4 130
METFORMIN HCL 278 240 5 14
NEXIUM 260 235 6 10
ATORVASTATIN CALCIUM 229 210 7 13
PIOGLITAZONE HCL 220 193 R 10 8 292
TRAMADOL HCL 214 179 9 15
EVISTA 211 206 10 212
ACTOPLUS MET 206 154 10 11 310
QUINAPRIL HCL 171 168 12 249
ACARBOSE 153 139 13 371
CIPROFLOXACIN HCL 141 110 14 32
ZOLPIDEM TARTRATE 127 104 15 17
SIMVASTATIN 119 94 16 2
LOSARTAN-HYDROCHLOROTHIAZIDE 118 117 17 57
CLOTRIMAZOLE-BETAMETHASONE 116 91 18 328
MICARDIS HCT 115 107 19 405
MELOXICAM 113 107 20 27
VICTOZA 3-PAK 111 86 21 313
PEN NEEDLE 102 91 22 96
FORTEO 94 82 23 307
TRAMADOL HCL-ACETAMINOPHEN 90 80 24 142
FUROSEMIDE 89 70 25 7
ZETIA 88 64 26 100
LISINOPRIL 80 79 27 4
BYETTA 79 53 28 446
PIOGLITAZONE-METFORMIN 78 62 R 10 29 449
VOLTAREN 75 58 30 187
PRANDIN 74 49 31 341
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 66 31 91
ENALAPRIL MALEATE 68 55 33 62
NATEGLINIDE 67 62 34 289
OMEPRAZOLE 67 56 34 5
LOVASTATIN 65 45 36 132
DIGOXIN 63 56 37 33
LIPITOR 61 54 38 128
PRENATAL PLUS 59 42 39 486
BENAZEPRIL HCL 59 49 39 193
HYDROCHLOROTHIAZIDE 56 51 41 29
HYDROCODONE-ACETAMINOPHEN 55 31 S3 42 1
CELEBREX 52 52 43 115
SINGULAIR 50 46 44 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.